Health ❯ Healthcare ❯ Clinical Trials

Cardiovascular Health

Heart Failure Antiplatelet Therapy Cholesterol Management Evolocumab Lipid-Lowering Therapy LDL Cholesterol Ziltivekimab Beta Blockers Beta-blocker Therapy Cannabidiol Safety

Atorvastatin Cuts Major Cardiovascular Events by 30% in Adults 70 and Older

The STAREE randomized trial’s findings strengthen the case for updating prevention guidelines for older adults.

Milvexian Fails to Cut Heart Attack, Stroke or Death After Acute Coronary Syndrome

Aficamten Improves Symptoms and Exercise Capacity in Nonobstructive HCM

Tenax Therapeutics Stock Collapses After Phase 3 Levosimendan Trial Misses Endpoints

Novo Nordisk’s Ziltivekimab Lowers Inflammation but Fails to Reduce Major Heart Events

Single Infusion Gene Editing Lowers LDL by Up to 62% in Early Trial

Lilly’s Oral Foundayo Matches Insulin on Heart Safety in Major Diabetes Trial

Personalized Vitamin D Strategy Halves Risk of Repeat Heart Attack in Randomized Trial

Alirocumab After Heart Transplant Slashes LDL but Doesn’t Slow One-Year Plaque, CAVIAR Trial Finds

Oral PCSK9 Pill Enlicitide Cuts LDL Up to 60% in Phase 3 Trial

ESC Trials Recast Antiplatelet Strategies After PCI and CABG

Beta-Blockers After Heart Attack Show Mixed Results, Benefit Seen at 40–49% EF

Ionis’ Olezarsen Slashes Triglycerides, Cuts Pancreatitis in Phase 3 Trials

ESC Trials Back Shorter Antiplatelet Therapy for Selected MI Patients

Mounjaro Rivals Trulicity in Cardiovascular Safety and Lowers All-Cause Mortality

Obicetrapib Shows Promise in Reducing LDL Cholesterol and Lp(a) in High-Risk Patients

Model Lottie Moss Hospitalized After Misusing Ozempic for Weight Loss

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks